Teva's sales declined by 8.4 percent to $31.2 million in the second quarter, and Ugg's sales decreased by 6.9 percent to $100.4 million, and Sanuk went up by 7.5 percent to $30.1 million. Together, the three brands had a 2.5 percent drop in second-quarter revenues to $170.1 million.